{"id":{"repo_id":"catania","oai_identifier":"oai:www.iris.unict.it:20.500.11769/587253"},"canonical_url":"https://search.dev.ndltd.org/etd/catania/oai:www.iris.unict.it:20.500.11769/587253","repository":{"repo_id":"catania","name":"Università degli Studi di Catania","base_url":"https://www.iris.unict.it/oai/request"},"display":{"title":"ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE","abstract":"anagrelide and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins in patients with essential thrombocythemia,","abstract_html":"anagrelide and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins in patients with essential thrombocythemia,","abstract_has_math":false,"creators":["FERLITO, CARMEN"],"institution":"Università degli studi di Catania","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["CACCIOLA, Rossella Rosaria","FERRO, Alfredo"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012-12-09","date_published":"2012-12-09","updated_at":"2026-07-24T01:35:06Z","subjects":["anagrelide,fgf-2,thrombocythemia,angrelide,"],"languages":["ita"],"rights":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/20.500.11769/587253","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Ferlito, Carmen","CACCIOLA, Rossella Rosaria","FERRO, Alfredo"]},{"key":"dc:creator","label":"Author","values":["FERLITO, CARMEN"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2012-12-09"]},{"key":"dc:publisher","label":"Institution","values":["Università degli studi di Catania","place:Catania"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["anagrelide,fgf-2,thrombocythemia,angrelide,"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["ita"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/20.500.11769/587253"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["anagrelide and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins in patients with essential thrombocythemia,"]},{"key":"dc:title","label":"Title","values":["ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE"]}]}],"canonical_facts":{"dc:contributor":["Ferlito, Carmen","CACCIOLA, Rossella Rosaria","FERRO, Alfredo"],"dc:creator":["FERLITO, CARMEN"],"dc:date":["2012-12-09"],"dc:description":["anagrelide and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins in patients with essential thrombocythemia,"],"dc:identifier":["https://hdl.handle.net/20.500.11769/587253"],"dc:language":["ita"],"dc:publisher":["Università degli studi di Catania","place:Catania"],"dc:rights":["info:eu-repo/semantics/openAccess","license:PUBBLICO - Pubblico con Copyright","license uri:iris.PUB02"],"dc:subject":["anagrelide,fgf-2,thrombocythemia,angrelide,"],"dc:title":["ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE"],"dc:type":["info:eu-repo/semantics/doctoralThesis"]},"updated_at":"2026-07-24T01:35:06Z"}